Suma Ramadas, PhDMedical Affairs
Matthew DurhamOmnidynamic Marketing
David LinetskyPoint-of-Care Marketing
Matt TurnerPatient Affordability
Stacey GandlerBrand Nourishment
Pat PurcellMeeting Engagement
Joey CohenMedication Adherence
Brenda SnowAuthentic Patient Voice
Frank BurrellScientific Storytelling
Daniel SontupeMarket Access
Liz KaneImpactful Strategy
Amy GilesIncreasing Engagement
Bud BilanichSuccess Coach
Paul TheisenPatient Acquisition
39% ORR for G100+pembrolizumab is greater than either agent alone; reaches 57% ORR in ...
WALTHAM, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email